Paragon 28, Inc. (NYSE:FNA) Major Shareholder Mvm Partners, Llc Sells 4,256 Shares

Paragon 28, Inc. (NYSE:FNA) major shareholder Mvm Partners, Llc sold 4,256 shares of the company’s stock in a transaction on Wednesday, November 27th. The stock was sold at an average price of $10.00, for a total transaction of $42,560.00. Following the completion of the sale, the insider now owns 10,499,960 shares of the company’s stock, valued at approximately $104,999,600. The trade was a 0.04 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Large shareholders that own more than 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

Mvm Partners, Llc also recently made the following trade(s):

• On Monday, November 25th, Mvm Partners, Llc sold 10,835 shares of Paragon 28 stock. The stock was sold at an average price of $10.09, for a total transaction of $109,325.15.
• On Friday, November 22nd, Mvm Partners, Llc sold 72,133 shares of Paragon 28 stock. The stock was sold at an average price of $10.16, for a total transaction of $732,871.28.
• On Wednesday, November 20th, Mvm Partners, Llc sold 147,581 shares of Paragon 28 stock. The stock was sold at an average price of $10.28, for a total transaction of $1,517,132.68.

Paragon 28 Price Performance

Shares of NYSE FNA opened at $10.31 on Friday. The company has a current ratio of 3.50, a quick ratio of 1.60 and a debt-to-equity ratio of 0.79. The stock has a fifty day simple moving average of $7.02 and a two-hundred day simple moving average of $7.29. Paragon 28, Inc. has a 1-year low of $4.65 and a 1-year high of $14.79. The firm has a market cap of $863.15 million, a price-to-earnings ratio of -13.93 and a beta of 1.01.

Paragon 28 (NYSE:FNA) last posted its quarterly earnings results on Tuesday, November 12th. The company reported ($0.15) earnings per share for the quarter, topping the consensus estimate of ($0.16) by $0.01. Paragon 28 had a negative return on equity of 37.90% and a negative net margin of 25.31%. The company had revenue of $62.30 million during the quarter, compared to the consensus estimate of $60.58 million. During the same quarter in the prior year, the company earned ($0.10) EPS. The firm’s quarterly revenue was up 18.0% compared to the same quarter last year. Analysts anticipate that Paragon 28, Inc. will post -0.66 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on the company. Canaccord Genuity Group decreased their price target on Paragon 28 from $17.00 to $15.00 and set a “buy” rating for the company in a research report on Wednesday, November 13th. Needham & Company LLC raised their target price on Paragon 28 from $11.00 to $13.00 and gave the company a “buy” rating in a research report on Wednesday, November 13th. Finally, Piper Sandler reissued an “overweight” rating and issued a $12.00 price target (down from $15.00) on shares of Paragon 28 in a report on Friday, August 9th. Five investment analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the stock currently has an average rating of “Buy” and an average target price of $15.60.

Hedge Funds Weigh In On Paragon 28

Several large investors have recently modified their holdings of the business. Nisa Investment Advisors LLC boosted its holdings in Paragon 28 by 46,660.0% in the 2nd quarter. Nisa Investment Advisors LLC now owns 4,676 shares of the company’s stock worth $32,000 after buying an additional 4,666 shares during the period. Levin Capital Strategies L.P. bought a new position in shares of Paragon 28 in the second quarter worth $68,000. Intech Investment Management LLC purchased a new position in shares of Paragon 28 in the third quarter valued at $70,000. Price T Rowe Associates Inc. MD grew its position in shares of Paragon 28 by 16.3% in the first quarter. Price T Rowe Associates Inc. MD now owns 12,622 shares of the company’s stock valued at $156,000 after purchasing an additional 1,766 shares in the last quarter. Finally, Ballentine Partners LLC bought a new stake in shares of Paragon 28 during the 3rd quarter valued at $91,000. Hedge funds and other institutional investors own 63.57% of the company’s stock.

Paragon 28 Company Profile

Paragon 28, Inc develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems.